CARDIOVASCULAR
hamburger
Merlin@home System

PORTFOLIO OVERVIEW

  • Enabling early clinical intervention
  • Improving clinical outcomes1
  • Increasing the probability of survival2,3
  • Delivering efficient and comprehensive care

 

EMPOWERING CARE WITH EFFECTIVE REMOTE MONITORING

Clinical studies show that remote monitoring reduces time to detect clinical events,4 reduces hospitalizationsand reduces all-cause mortality over three years.6 Remote monitoring not only increases the quality of patient care for patients, but improves clinical efficiency and substantially reduces health care costs.6

Our remote monitoring products are designed to give you the options you need to precisely diagnose, treat and manage arrhythmias with versatility and efficacy. With them, you can optimize your workflow, support informed clinical decisions and deliver efficient, comprehensive patient care.

 

A woman works in her garden

REDUCED RISK,
REDUCED MORTALITY2,3

Activating a remote transmitter can more than double a patient’s probability of survival.2,3

PRODUCTS IN THIS PORTFOLIO

NA
PROACTIVE CARE AND CONVENIENCE

With remote monitoring, data automation and alerts, you can leverage more efficient remote follow-ups instead of in-office visits to gain the opportunity for more timely clinical interventions.

  • Patient convenience: Distance to the hospital makes frequent in-person evaluations of devices difficult, especially when increasingly frequent follow-ups are needed, e.g., near the end of a device’s battery life. Remote follow-ups let patients avoid difficult and expensive travel.7,8
  • Clinician convenience: Remote monitoring saves you and your staff time without lowering patient satisfaction, even if the number of patients with devices increases.7,8

Our wireless remote monitoring, with the Merlin.net™ Patient Care Network (PCN) and Merlin@home™ Transmitter, works with our featured defibrillators and pacemakers, including the Assurity MRI™ pacemaker

IMPROVED QUALITY OF CARE

Remote monitoring enables early diagnosis of technical or clinical issues, which facilitates early clinical intervention if needed. Clinical benefits, as seen in clinical trials, include:

  • 79% reduction in time to detection of clinical events4
  • 66% reduction in hospitalizations for atrial arrhythmia and related stroke4
  • 50% reduction in relative risk of death1
  • 34% reduction in all-cause mortality over 3 years for ICD/CRT-D patients5
  • 27% reduction in all-cause mortality over 3 years for pacemaker patients5

Activating a remote transmitter can more than double a patient’s probability of survival,2,3 and patients with the highest adherence to remote monitoring have seen the highest probability of survival. 2,3 You can begin monitoring your patient immediately after a device is implanted, and such use is crucial to realizing the full value of a remote monitoring system.

We have especially strong clinical evidence showing the benefits of remote monitoring in early stroke intervention10.

Survival graphic
ECONOMIC EVIDENCE


At Abbott, we are dedicated to improving clinical outcomes while also reducing health care costs. Remote monitoring is a critical tool in population health management and addresses disease states that contribute greatly to high health care costs, including atrial fibrillation and heart failure.

Remote monitoring starts working from day one and can lower health care costs by reducing:

  • The number of in-hospital device evaluations9
  • The number of hospital admissions4
  • The length of stay per cardiac hospitalization4
  • Potential follow-up office visits9
Reduction in spending graphic
REMOTE MONITORING WITH THE CARDIOMEMS™ HF SYSTEM

Our remote monitoring is not restricted to cardiac arrhythmia management. We also offer the CardioMEMS™ HF System, which is the first and only FDA-approved wireless heart failure (HF) monitor and accurately measures pulmonary artery pressure.

Learn more about the CardioMEMS HF System

CardioMEMS HF System
RESOURCES AND DOCUMENTATION
REFERENCES
1. Saxon, L. A., Hayes, D. L., Gilliam, F. R., Heidenriech, P. A., Day, J., Seth, M., … Boehmer, J. P. (2010). Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: The ALTITUDE survival study. Circulation, 122, 2359-2367. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.960633
2. Mittal, S., Piccini, J., Fischer, A., Snell, J., Dalal, N., & Varma, N. (2014, May). Remote monitoring of ICD patients is associated with reduced mortality irrespective of device type. Presented at the meeting of the Heart Rhythm Society, San Francisco, CA. This was a retrospective data review and had limitations.
3. Mittal, S., Piccini, J., Fischer, A., Snell, J., Dalal, N., & Varma, N. (2014, May). Increased adherence to remote monitoring is associated with reduced mortality in both pacemaker and defibrillator patients. Presented at the meeting of the Heart Rhythm Society, San Francisco, CA. This was a retrospective data review and has limitations.
4. Mabo, P., Victor, F., Bazin, P., Ahres, S., Babuty. D., Da Costa, A., ... Dauber, J. C., & COMPAS Trial Investigators. (2012). COMPAS Trial Investigators. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). European Heart Journal, 33, 1105-1111. http://dx.doi.org/10.1093/eurheartj/ehr419
5. Sutton, B., Zigler, J., Gopinathannair, R., Deam, G., & Graver, R. (2013). Improved health outcomes and cost-savings with remote monitoring of cardiac implantable electronic devices. Presented at the meeting of the Heart Rhythm Society, Denver, CO. Retrospective claims analysis of Medicare 5% sample Limited Data Set Standard Analytical Files claims and enrollment data across all manufacturers.
6. Varma N, Piccini JP, Snell J, Fischer A, Dalal N and Mittal S. Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients. J Am Coll Cardiol. 2015. 65(24):2601-2610.http://dx.doi.org/10.1016/j.jacc.2015.04.033
7. Masella, C., Zanaboni, P., Di Stasi, F., Gilardi, S., Ponzi, P., & Valsecchi, S. (2008). Assessment of a remote monitoring system for implantable cardioverter defibrillators. Journal of Telemedicine and Telecare, 14, 290-294. http://dx.doi.org/10.1258/jtt.2008.080202
8. Marzegalli, M., Lunati, M., Landolina, M., Perego, G. B., Ricci, R. P., Guenzati, G., ... Schirru, M. (2008). Remote monitoring of CRT–ICD: The multicenter Italian CareLink evaluation—ease of use, acceptance, and organizational implications. Pacing and Clinical Electrophysiology, 31, 1259-1264. http://dx.doi.org/10.1111/j.1540-8159.2008.01175.x
9. Varma, N., Epstein, A. E., Irimpen, A., Schweikert, R., Love, C., & TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter defibrillator follow-up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) trial. Circulation, 122, 325-332. http://dx.doi.org/10.1161/circulationaha.110.937409
10.Healey JS, Connolly SJ, Gold MR, et al. Sub-clinical atrial fibrillation and the risk of stroke: A Symptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the AF Reduction atrial pacing Trial (ASSERT). N Engl J Med. 2012;366:120-9.
 
CUSTOMER
SERVICE

Our customer service experts can help with your
product orders or questions

OUR PRODUCTS

See our featured innovations and technologies, full product catalog and approach to disease state management.

SJM-CV WEB-0718-0012

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

true
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?